Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
D000017:ABO Blood-Group System; D001777:Blood Coagulation; D001799:Blood Sedimentation; D001809:Blood Viscosity; D002318:Cardiovascular Diseases / Q000503:physiopathology*; D002449:Cell Aggregation; D003920:Diabetes Mellitus / Q000503:physiopathology; D004912:Erythrocytes; D005340:Fibrinogen; D006084:Graft Rejection; D006400:Hematocrit; D006467:Hemophilia A / Q000503:physiopathology; D006801:Humans; D006980:Hyperthyroidism / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000503:physiopathology; D016030:Kidney Transplantation; D008545:Melanoma / Q000503:physiopathology*; D009203:Myocardial Infarction / Q000503:physiopathology; D011379:Prognosis; D012212:Rheology; D012709:Serum Albumin / Q000032:analysis; D013927:Thrombosis; D014184:Transplantation, Homologous
D000017:ABO Blood-Group System; D012709:Serum Albumin; D005340:Fibrinogen